Home › Generics › Casirivimab + Imdevimab

Casirivimab + Imdevimab

This is indicated for: Treatment of COVID-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID-19. Prevention of COVID-19 in adults and adolescents aged 12 years and older weighing at least 40 kg.

brands

Filter:

Sort:

Brand NameDosage FormCompanyStrengthPrice

⊕Ronapreve

Injection

Roche Bangladesh Ltd.

300 mg/2.5 ml & 300 mg/2.5 ml